|
|
||||||||
Technical Briefs |
1 Service dHématologie-Oncologie, Centre de Recherche, Hôpital Sainte-Justine, Montréal (Québec), H3T 1C5 Canada
2 Département de Pédiatrie, Université de Montréal, Montreal (Quebec), H3T 1C5 Canada
aaddress correspondence to this author at: Centre de Recherche, Hôpital Sainte-Justine, 3175 Côte Ste-Catherine, Montréal (Québec), H3T 1C5 Canada; fax 514-345-4731, e-mail maja.krajinovic@umontreal.ca
| The first 300 words of the full text of this article appear below. |
Glucocorticoids (GCs) have a major antiproliferative effect, which has led to the use of their synthetic homologs for immunosuppression, treatment of inflammation, and induction of cytotoxicity (1)(2). GCs exert their effect by binding to an intracellular GC receptor (GR), forming a complex that translocates to the nucleus, where GCs then regulate the expression of target genes interacting with promoter GC-responsive elements (1). The different GR forms, resulting from GR gene variability, can affect the regulation of many biological functions, such as hypothalamic-pituitary-adrenal axis regulation and GC responsiveness, thereby underlying susceptibility to many diseases. Indeed, GR mutations have been associated with altered cardiovascular function, metabolic disturbances, and hematologic malignancies (3)(4)(5). Likewise, functional GR variability might affect the therapeutic response to corticosteroid drugs (5). Identification of different GR gene variants may thus be helpful in assessing the role of the GR gene in disease susceptibility or in adjudging predisposition to corticosteroid-associated adverse drug reactions.
Several polymorphisms of the GR gene, which might have an impact on GC sensitivity, have been reported (6)(7)(8). Among these, the BclI polymorphism was identified by Southern blotting using human GR cDNA-specific probes (9) that identified two alleles with fragment lengths of 4.5 and 2.3 kb. Several clinical investigations have subsequently suggested that this GR polymorphism is linked to altered GR function (6)(10)(11)(12)(13)(14)(15). An association between the BclI polymorphism and changes in tissue-specific corticosteroid sensitivity, as well as with poor feedback regulation of the hypothalamic-pituitary-adrenal axis, has been reported (6)(10). This was further documented by association of the BclI polymorphism with abdominal obesity (11
The following articles in journals at HighWire Press have cited this article:
![]() |
W. J.E. Tissing, J. P.P. Meijerink, M. L. den Boer, B. Brinkhof, E. F.C. van Rossum, E. R. van Wering, J. W. Koper, P. Sonneveld, and R. Pieters Genetic Variations in the Glucocorticoid Receptor Gene Are Not Related to Glucocorticoid Resistance in Childhood Acute Lymphoblastic Leukemia Clin. Cancer Res., August 15, 2005; 11(16): 6050 - 6056. [Abstract] [Full Text] [PDF] |
||||
![]() |
E B Lee, J Y Kim, Y J Lee, and Y W Song Glucocorticoid receptor polymorphisms in Korean patients with rheumatoid arthritis Ann Rheum Dis, March 1, 2005; 64(3): 503 - 504. [Full Text] [PDF] |
||||
Read all eLetters
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |